ArticleCureus2026
A Long-Term Comparison of Periprosthetic Femoral Bone Mineral Density Between a Short and a Standard Stem Used in Total Hip Arthroplasty.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimShort femoral stems in total hip arthroplasty (THA) were developed to preserve proximal femoral bone stock by minimizing stress shielding. However, their long-term outcomes remain debated when compared to standard-length stems. We hypothesized that short stems would allow better preservation of proximal periprosthetic bone mineral density (BMD) compared to standard stems. The primary objective of this study was to evaluate long-term periprosthetic BMD in patients receiving either short or standard femoral stems, with the hypothesis that short stems would provide superior preservation of proximal bone. The secondary objective included the comparison of clinical and radiological outcomes.
methodsThis single-center retrospective study included patients who underwent THA between 2010 and 2018 using either the Optimys short femoral stem (Bettlach, Switzerland: Mathys) or the standard-length twinSys stem (Bettlach, Switzerland: Mathys). Periprosthetic BMD was evaluated using dual-energy X-ray absorptiometry (DEXA) across six modified Gruen zones. Radiographs were evaluated by two reviewers and clinical outcomes were evaluated using the Harris Hip Score (HHS) and the presence or absence of thigh pain.
resultsAt a mean follow-up of 9.4 years, the analysis of 24 hips (10 short stems, 14 standard stems) revealed no significant differences in periprosthetic BMD. Clinical outcomes, including HHS (median {IQR}; standard: 95.8 {80.8-100.0}; short: 88.4 {80.0-93.0}) and thigh pain incidence, were comparable, and radiographic evaluation revealed no difference in stress shielding or osteolysis.
conclusionsOur findings suggest that, over the long term, both the Optimys and twinSys stems are subject to stress shielding. These results contrast with some prior studies and highlight the potential influence of stem design and follow-up duration on bone remodeling outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.